logo
Select company
Select metric
-126.03%EBIT Margin
VS
Market
12
Sector
36
Industry
64
History
87
$ 6.33Close
$ 2.3 - $ 10.36 52-Week Range
Ticker Information

Ticker

XBIO

Company Name

XENETIC BIOSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

XENETIC BIOSCIENCES INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XBIO - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -3.08M-126.03%$ 2.45M
3/31/2025$ -3.67M-142.03%$ 2.58M
12/31/2024$ -3.96M-158.39%$ 2.5M
9/30/2024$ -4.08M-161.58%$ 2.52M
6/30/2024$ -4.7M-186.33%$ 2.52M
3/31/2024$ -4.47M-182.95%$ 2.44M
12/31/2023$ -4.13M-162.78%$ 2.54M
9/30/2023$ -4.45M-188.77%$ 2.35M
6/30/2023$ -4.19M-194.34%$ 2.16M
3/31/2023$ -5.82M-302.29%$ 1.92M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • XENETIC BIOSCIENCES INC's latest trailing twelve months (TTM) EBIT % stands at -4553.45%.
  • Over the past 5 years, XENETIC BIOSCIENCES INC's average EBIT % has been -831.09%.
  • The median EBIT % for XENETIC BIOSCIENCES INC during this period was -343.08%
  • XENETIC BIOSCIENCES INC reached its highest EBIT % over the past 5 years at -126.03%.
  • The lowest EBIT % recorded by XENETIC BIOSCIENCES INC in the same timeframe -4553.45%

XENETIC BIOSCIENCES INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
ONCO : ONCONETIX INC -3321.76%SPRB : SPRUCE BIOSCIENCES INC -3549.11%NAOV : NANOVIBRONIX INC -201.24%SXTP : 60 DEGREES PHARMACEUTICALS INC -918.16%VIVS : VIVOSIM LABS INC -1389.44%DRMA : DERMATA THERAPEUTICS INC -SLRX : SALARIUS PHARMACEUTICALS INC -GLTO : GALECTO INC -TOVX : THERIVA BIOLOGICS INC -REVB : REVELATION BIOSCIENCES INC -

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for XENETIC BIOSCIENCES INC is calculated as follows: EBIT [ $ -13.78M ] / Revenues [ $ 302.68K ]
(=) EBIT % [ -4553.45% ]

XBIO - EBIT Margin, Last 5 years

-4553.45%

Minimum

Sep 30, 2020

-126.03%

Maximum

Jun 30, 2025

-831.09%

Average

-343.08%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%